Indeed it did and I am getting the impression you assumed I was baiting. I was not - I simply proffered a chart perspective.I am taking the opportunity to provide an updated one and I sincerely hope it works out for all holders
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%